MDCN Stock Overview
A bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medican Enterprises, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -99.00% |
| 5 Year Change | -99.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDCN | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 0.5% |
| 1Y | 0% | 13.1% | 30.7% |
Return vs Industry: MDCN underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: MDCN underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| MDCN volatility | |
|---|---|
| MDCN Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine MDCN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Kelvin Lindsey | www.medicaninc.com |
Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.
Medican Enterprises, Inc. Fundamentals Summary
| MDCN fundamental statistics | |
|---|---|
| Market cap | US$38.94k |
| Earnings (TTM) | -US$134.80m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs MDCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDCN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$134.80m |
| Earnings | -US$134.80m |
Last Reported Earnings
Mar 31, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MDCN perform over the long term?
See historical performance and comparison